Uncontrolled T2D in India: Valuable Consideration for Dapagliflozin Sitagliptin Combination Dr. D.C. Sharma25 July 2025 12:11 PM ISTIndia accounts for 1 in 7 adults living with diabetes globally. An estimated 89.8 million adults aged 20-79 years in India are living with diabetes,...
Beyond BMI: Why Pioglitazone Deserves a Place in Managing 'Thin-Fat' Type 2 Diabetes in India Dr. Kaushik Pandit26 Jun 2025 11:03 AM ISTThin-Fat Paradox in Indian T2DM - A Distinct Metabolic Challenge: In the Indian population, the 'thin-fat' phenotype-normal BMI with excess visceral...
Prediabetes and CKD: An Overlooked Interaction in Early Metabolic Disease Dr. Gayatri S11 Jun 2025 11:06 AM ISTPrediabetes and CKD: A Growing Double BurdenThe rising prevalence of prediabetes and chronic kidney disease (CKD) in India reflects an...
Relevance of Pioglitazone in Indian T2DM Care Continuum Dr. Vijay Panikar27 May 2025 11:30 AM ISTIndia is experiencing a rising burden of type 2 diabetes (T2D), affecting 11.4% of adults. Hypertension (35.5%), generalized obesity (28.6%),...
Re-visiting the Role of Pneumococcal Vaccination in Patients with Cardiovascular Diseases Dr. Sanjay Mittal14 May 2025 11:37 AM ISTCardiovascular diseases (CVD) account for 24.8% of all deaths in India, with an age-standardized death rate of 272 per 100,000-higher than the global...
Addressing Pneumococcal Disease in CKD Patients: A Call for Preventive Action Dr. Alan Almeida22 Jan 2025 11:49 AM ISTIn India, the prevalence of chronic kidney disease (CKD) has reached epidemic proportions, with population-based studies reporting a prevalence...
Revolutionizing COPD Care: The Role Of Pneumococcal Vaccines in Enhancing Patient Outcomes Dr Rajesh V11 Oct 2024 12:00 PM ISTExacerbations are recognized to be crucial acute events that are associated with increased hospitalization rates and worsening clinical outcomes. Both...
Harmonizing Adult Vaccination Guidelines in India: Need of the Hour (Prof) Dr Agam Vora6 Jun 2024 12:36 PM ISTA. Need for Adult ImmunizationVaccine-preventable diseases (VPDs) are among the various diseases that threaten India's healthcare system. From this...
Applicability of FDC of Linagliptin and Dapagliflozin in T2DM: EVERGREEN Case Report Summaries Dr Jeegar Dattani24 May 2024 11:00 AM ISTThe EVERGREEN webinar, designed to guide physicians regarding the care of people with diabetes, highlighted the clinical applicability of a...
Linagliptin and Dapagliflozin: Evidence for Robust Glycemic Control and Reaping CV-CKD Benefits in T2DM (EVERGREEN) Practice Perspective Dr. Kamal Kant Kohli21 Nov 2023 12:14 PM ISTType 2 diabetes mellitus (T2DM) is growing alarmingly due to rapid urbanization, migration, aging population, and lifestyle changes; with Asia being...
Considering Probiotic in CKD: Exploring Complementary Effect on Protein Metabolism Dr Kartikeya Kohli27 Oct 2023 12:45 PM ISTChronic kidney disease(CKD) has emerged as one of the leading non-communicable causes of death globally, and its burden is anticipated to rise in the...
Probiotics Reduce CKD Progression and Improve Survival Outcomes Dr Kartikeya Kohli25 Aug 2023 11:15 AM ISTChronic kidney disease (CKD) is one of the debilitating chronic conditions affecting over 800 million people worldwide.[1] It is often referred to as...
